Feature

With many employers still blind to the financial burden of employee sickness absence on their companies, Professor Michael O'Donnell explains what firms can do to curtail costs.

With the results of the FSA's Retail Distribution Review looming, Stephanie Spicer analyses the potential outcomes of the report and how vastly divergent the two main scenarios could prove to be.

The ongoing Northern Rock saga has left consumer trust in the financial services industry in tatters. But, as Peter Carvill finds out, those with high personal debt cannot have it both ways.

While markedly more successful at a corporate level, private medical insurance could offer today's health-conscious public exactly what they want if only it was packaged better, writes Dave Priestley.

With the NHS in a state of turmoil, Lucy Quinton explores the benefits of private medical insurance, and how important it is for the future health of the UK public.

Prudential's new product, PruProtect, has caused a bit of a stir in the market. Adviser Dale Tranter outlines what he thinks about the offering and how it matches up to its predecessor.

With numerous types of epilepsy and a variety of different kinds of epileptic seizure, underwriting for customers living with the condition can be troublesome. Vanessa Leyland fills in the gaps.

From its conception by Dr Marius Barnard to its current incarnation, critical illness cover has changed dramatically. Bonnie Burns reports on how the product must continue to move with the times.

With the results from COVER's latest annual Insight research revealed, Peter Carvill looks at trends in the protection industry and the effect they are having on intermediaries.